These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 17234669

  • 1. Binding of highly concentrated maxacalcitol to the nuclear vitamin D receptors of parathyroid cells.
    Shiizaki K, Hayakawa N, Imazeki I, Hatamura I, Okada T, Negi S, Sakaguchi T, Shigematsu T, Akizawa T.
    Nephrol Dial Transplant; 2007 Apr; 22(4):1078-86. PubMed ID: 17234669
    [Abstract] [Full Text] [Related]

  • 2. Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats.
    Shiizaki K, Negi S, Hatamura I, Sakaguchi T, Saji F, Kunimoto K, Mizobuchi M, Imazeki I, Ooshima A, Akizawa T.
    J Am Soc Nephrol; 2005 Jan; 16(1):97-108. PubMed ID: 15574509
    [Abstract] [Full Text] [Related]

  • 3. Direct maxacalcitol injection into hyperplastic parathyroids improves skeletal changes in secondary hyperparathyroidism.
    Shiizaki K, Hatamura I, Negi S, Sakaguchi T, Saji F, Kunimoto K, Okamoto M, Imazeki I, Muragaki Y, Akizawa T.
    Kidney Int; 2006 Aug; 70(3):486-95. PubMed ID: 16788697
    [Abstract] [Full Text] [Related]

  • 4. Highly concentrated calcitriol and its analogues induce apoptosis of parathyroid cells and regression of the hyperplastic gland--study in rats.
    Shiizaki K, Hatamura I, Negi S, Sakaguchi T, Saji F, Imazeki I, Kusano E, Shigematsu T, Akizawa T.
    Nephrol Dial Transplant; 2008 May; 23(5):1529-36. PubMed ID: 18156462
    [Abstract] [Full Text] [Related]

  • 5. Molecular and morphological approach of uremia-induced hyperplastic parathyroid gland following direct maxacalcitol injection.
    Shiizaki K, Hatamura I, Nakazawa E, Ogura M, Masuda T, Akizawa T, Kusano E.
    Med Mol Morphol; 2008 Jun; 41(2):76-82. PubMed ID: 18592161
    [Abstract] [Full Text] [Related]

  • 6. Direct injection of calcitriol or its analog improves abnormal gene expression in the hyperplastic parathyroid gland in uremia.
    Shiizaki K, Fukagawa M, Yuan Q, Hatamura I, Nii-Kono T, Saji F, Shigematsu T, Akizawa T.
    Am J Nephrol; 2008 Jun; 28(1):59-66. PubMed ID: 17901691
    [Abstract] [Full Text] [Related]

  • 7. Direct injection of calcitriol or its analog into hyperplastic parathyroid glands induces apoptosis of parathyroid cells.
    Shiizaki K, Negi S, Hatamura I, Tatsuta K, Shibata M, Shimada S, Sakaguchi T, Akizawa T.
    Kidney Int Suppl; 2006 Jul; (102):S12-5. PubMed ID: 16810304
    [Abstract] [Full Text] [Related]

  • 8. Percutaneous maxacalcitol injection therapy regresses hyperplasia of parathyroid and induces apoptosis in uremia.
    Shiizaki K, Hatamura I, Negi S, Narukawa N, Mizobuchi M, Sakaguchi T, Ooshima A, Akizawa T.
    Kidney Int; 2003 Sep; 64(3):992-1003. PubMed ID: 12911549
    [Abstract] [Full Text] [Related]

  • 9. Local NF-κB Activation Promotes Parathyroid Hormone Synthesis and Secretion in Uremic Patients.
    Mao J, Wang M, Ni L, Gong W, Jiang X, Zhang Q, Zhang M, Wen D, Chen J.
    Endocrinology; 2021 Jul 01; 162(7):. PubMed ID: 33912936
    [Abstract] [Full Text] [Related]

  • 10. The induction of C/EBPβ contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease.
    Arcidiacono MV, Yang J, Fernandez E, Dusso A.
    Nephrol Dial Transplant; 2015 Mar 01; 30(3):423-33. PubMed ID: 25294851
    [Abstract] [Full Text] [Related]

  • 11. Vitamin D receptor agonist VS-105 directly modulates parathyroid hormone expression in human parathyroid cells and in 5/6 nephrectomized rats.
    Sawada K, Wu-Wong JR, Chen YW, Wessale JL, Kanai G, Kakuta T, Fukagawa M.
    J Steroid Biochem Mol Biol; 2017 Mar 01; 167():48-54. PubMed ID: 27989797
    [Abstract] [Full Text] [Related]

  • 12. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor, calcium sensing receptor, and cell cycle regulating factors.
    Tokumoto M, Taniguchi M, Matsuo D, Tsuruya K, Hirakata H, Iida M.
    Ther Apher Dial; 2005 Aug 01; 9 Suppl 1():S27-34. PubMed ID: 16109139
    [Abstract] [Full Text] [Related]

  • 13. Suppression of parathyroid hormone secretion in CAPD patients by intraperitoneal administration of Maxacalcitol.
    Murakami K, Miyachi H, Watanabe A, Kawamura N, Fujii M, Koide S, Murase M, Kushimoto H, Hasegawa M, Tomita M, Hiki Y, Sugiyama S.
    Clin Exp Nephrol; 2004 Jun 01; 8(2):134-8. PubMed ID: 15235930
    [Abstract] [Full Text] [Related]

  • 14. Improvement of impaired calcium and skeletal homeostasis in vitamin D receptor knockout mice by a high dose of calcitriol and maxacalcitol.
    Shiizaki K, Hatamura I, Imazeki I, Moriguchi Y, Sakaguchi T, Saji F, Nakazawa E, Kato S, Akizawa T, Kusano E.
    Bone; 2009 Nov 01; 45(5):964-71. PubMed ID: 19631778
    [Abstract] [Full Text] [Related]

  • 15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 01; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 16. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
    Brown AJ, Zhong M, Finch J, Ritter C, Slatopolsky E.
    Endocrinology; 1995 Apr 01; 136(4):1419-25. PubMed ID: 7895652
    [Abstract] [Full Text] [Related]

  • 17. In vivo time-course of receptor binding in the parathyroid gland of the vitamin D analogue [(3)H]1,25-dihydroxy-22-oxavitamin D(3) compared with [(3)H]1,25-dihydroxyvitamin D(3), determined by micro-autoradiography.
    Koike N, Hayakawa N, Tokuda K, Nishimiya K, Saito K, Stumpf WE.
    Nephrol Dial Transplant; 2002 Apr 01; 17 Suppl 10():53-7. PubMed ID: 12386270
    [Abstract] [Full Text] [Related]

  • 18. Combination therapy of intravenous maxacalcitol and percutaneous ethanol injection therapy lowers serum parathyroid hormone level and calcium x phosphorus product in secondary hyperparathyroidism.
    Tanaka M, Itoh K, Matsushita K, Matsushita K, Fukagawa M.
    Nephron Clin Pract; 2006 Apr 01; 102(1):c1-7. PubMed ID: 16166800
    [Abstract] [Full Text] [Related]

  • 19. Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats.
    Slatopolsky E, Finch J, Ritter C, Takahashi F.
    Am J Kidney Dis; 1998 Oct 01; 32(2 Suppl 2):S40-7. PubMed ID: 9808142
    [Abstract] [Full Text] [Related]

  • 20. In vivo dose-related receptor binding of the vitamin D analogue [3H]-1,25-dihydroxy-22-oxavitamin D3 (OCT) in rat parathyroid, kidney distal and proximal tubules, duodenum, and skin, studied by quantitative receptor autoradiography.
    Koike N, Hayakawa N, Kumaki K, Stumpf WE.
    J Histochem Cytochem; 1998 Dec 01; 46(12):1351-8. PubMed ID: 9815276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.